PSAT106 Infigratinib in Children with Achondroplasia: Design of the PROPEL, PROPEL2 and PROPEL OLE Studies
Author(s) -
Elena Muslimova,
Josep Maria De Bergua,
Ravi Savarirayan,
Paul Arundel,
Helen McDevitt,
Valérie CormierDaire,
Vrinda Saraff,
Mars Skae,
Borja Delgado,
Antonio LeivaGea,
Fernando SantosSimarro,
JeanPierre Salles,
Marc Nicolino,
Massimiliano Rossi,
Pekka Kannus,
Michael B. Bober,
J. P. Phillips,
Howard M. Saal,
Paul Harmatz,
Christine Burren,
Garrett Gotway,
Terry Cho,
Richard Weng,
Daniela Rogoff,
Julie HooverFong,
Melita Irving
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1311
Subject(s) - achondroplasia , endochondral ossification , clinical endpoint , medicine , bone growth , adverse effect , clinical trial , endocrinology , pediatrics , anatomy , cartilage
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom